Announcement PDF Proposed issue of securities Announcement Summary Entity name ANTISENSE THERAPEUTICS LIMITED Announcement Type New announcement Date of this announcement 24/11/2023 The Proposed issue is: A placement or other type of issue Total number of +securities proposed to be issued for a placement or other type of issue Maximum Number of +securities to be issued ASX +security code +Security description New class-code to be confirmed Option with $0.07 exercise price, expiry 07 Aug 2028 6,669,000 New class-code to be confirmed Option with $0.061 exercise price, expiry 30 Jun 2028 3,000,000 Proposed +issue date 29/11/2023 Refer to next page for full details of the announcement Proposed issue of securities 1/7 Proposed issue of securities Part 1 - Entity and announcement details 1.1 Name of +Entity ANTISENSE THERAPEUTICS LIMITED We (the entity named above) give ASX the following information about a proposed issue of +securities and, if ASX agrees to +quote any of the +securities (including any rights) on a +deferred settlement basis, we agree to the matters set out in Appendix 3B of the ASX Listing Rules. If the +securities are being offered under a +disclosure document or +PDS and are intended to be quoted on ASX, we also apply for quotation of all of the +securities that may be issued under the +disclosure document or +PDS on the terms set out in Appendix 2A of the ASX Listing Rules (on the understanding that once the final number of +securities issued under the +disclosure document or +PDS is known, in accordance with Listing Rule 3.10.3C, we will complete and lodge with ASX an Appendix 2A online form notifying ASX of their issue and applying for their quotation). 1.2 Registered Number Type Registration Number ABN 41095060745 1.3 ASX issuer code ANP 1.4 The announcement is New announcement 1.5 Date of this announcement 24/11/2023 1.6 The Proposed issue is: A placement or other type of issue Proposed issue of securities 2/7 Proposed issue of securities Part 7 - Details of proposed placement or other issue Part 7A - Conditions 7A.1 Do any external approvals need to be obtained or other conditions satisfied before the placement or other type of issue can proceed on an unconditional basis? Yes 7A.1a Conditions Approval/Condition Date for determination +Security holder approval 15/11/2023 Is the date estimated or actual? Actual ** Approval received/condition met? Yes Comments Part 7B - Issue details Is the proposed security a 'New class' (+securities in a class that is not yet quoted or recorded by ASX) or an 'Existing class' (additional securities in a class that is already quoted or recorded by ASX)? New class Will the proposed issue of this +security include an offer of attaching +securities? No Details of +securities proposed to be issued ISIN Code (if Issuer is a foreign company and +securities are non CDIs) Have you received confirmation from Will the entity be seeking quotation ASX that the terms of the proposed of the 'new' class of +securities on +securities are appropriate and ASX? No equitable under listing rule 6.1? No ASX +security code +Security description New class-code to be confirmed Option with $0.07 exercise price, expiry 07 Aug 2028 +Security type Options Proposed issue of securities 3/7 Proposed issue of securities Number of +securities proposed to be issued 6,669,000 Offer price details Are the +securities proposed to be issued being issued for a cash consideration? No Please describe the consideration being provided for the +securities Resolution 4 Approval for issue of Options to Dr James Garner as approved by shareholders at AGM held 15 Nov 2023 Please provide an estimate of the AUD equivalent of the consideration being provided for the +securities 0.056400 Will all the +securities issued in this class rank equally in all respects from their issue date? Yes Options details +Security currency Exercise price Expiry date AUD - Australian Dollar AUD 0.0700 7/8/2028 Details of the type of +security that will be issued if the option is exercised ANP : ORDINARY FULLY PAID Number of securities that will be issued if the option is exercised One ANP ordinary fully paid share Please provide a URL link for a document lodged with ASX setting out the material terms of the +securities proposed to be issued or provide the information by separate announcement. NOM https://announcements.asx.com.au/asxpdf/20231017/pdf/05w4jll2904v0w.pdf Results of AGM https://announcements.asx.com.au/asxpdf/20231115/pdf/05xcw8t5cckw32.pdf Is the proposed security a 'New class' (+securities in a class that is not yet quoted or recorded by ASX) or an 'Existing class' (additional securities in a class that is already quoted or recorded by ASX)? New class Proposed issue of securities Will the proposed issue of this +security include an offer of attaching +securities? No 4/7 Proposed issue of securities Details of +securities proposed to be issued ISIN Code (if Issuer is a foreign company and +securities are non CDIs) Have you received confirmation from Will the entity be seeking quotation ASX that the terms of the proposed of the 'new' class of +securities on +securities are appropriate and ASX? No equitable under listing rule 6.1? No ASX +security code +Security description New class-code to be confirmed Option with $0.061 exercise price, expiry 30 Jun 2028 +Security type Options Number of +securities proposed to be issued 3,000,000 Offer price details Are the +securities proposed to be issued being issued for a cash consideration? No Please describe the consideration being provided for the +securities Resolution 6: Approval of Options Issue to Dr Charmaine Gittleson as approved by shareholders at AGM held 15 Nov 2023 Please provide an estimate of the AUD equivalent of the consideration being provided for the +securities 0.045000 Will all the +securities issued in this class rank equally in all respects from their issue date? Yes Options details +Security currency Exercise price Expiry date AUD - Australian Dollar AUD 0.0610 30/6/2028 Details of the type of +security that will be issued if the option is exercised ANP : ORDINARY FULLY PAID Number of securities that will be issued if the option is exercised One ANP ordinary fully paid share Please provide a URL link for a document lodged with ASX setting out the material terms of the +securities Proposed issue of securities 5/7 Proposed issue of securities Please provide a URL link for a document lodged with ASX setting out the material terms of the +securities proposed to be issued or provide the information by separate announcement. NOM https://announcements.asx.com.au/asxpdf/20231017/pdf/05w4jll2904v0w.pdf Results of AGM https://announcements.asx.com.au/asxpdf/20231115/pdf/05xcw8t5cckw32.pdf Part 7C - Timetable 7C.1 Proposed +issue date 29/11/2023 Part 7D - Listing Rule requirements 7D.1 Has the entity obtained, or is it obtaining, +security holder approval for the entire issue under listing rule 7.1? Yes 7D.1a Date of meeting or proposed meeting to approve the issue under listing rule 7.1 15/11/2023 7D.2 Is a party referred to in listing rule 10.11 participating in the proposed issue? Yes 7D.3 Will any of the +securities to be issued be +restricted securities for the purposes of the listing rules? No 7D.4 Will any of the +securities to be issued be subject to +voluntary escrow? No Part 7E - Fees and expenses 7E.1 Will there be a lead manager or broker to the proposed issue? No 7E.2 Is the proposed issue to be underwritten? No 7E.4 Details of any other material fees or costs to be incurred by the entity in connection with the proposed issue Proposed issue of securities 6/7 Proposed issue of securities Part 7F - Further Information 7F.01 The purpose(s) for which the entity is issuing the securities Issue of unlisted options pursuant to Resolutions 4 and 6 as approved by shareholders at the Annual General Meeting held on 15 November 2023 7F.1 Will the entity be changing its dividend/distribution policy if the proposed issue proceeds? No 7F.2 Any other information the entity wishes to provide about the proposed issue Proposed issue of securities 7/7